Invion eyes success with quit smoking drug
THE developer has successfully completed Phase 2 clinical trials for Nadolol in patients trying to quit smoking.
AUSTRALIAN drug developer Invion's migraine and blood pressure treatment drug Nadolol has found success as a new quit smoking agent.
RESULTS from its 155-patient, phase-two clinical trial indicate smokers administered with the drug are more likely to stop smoking completely, or dramatically reduce the number of cigarettes smoked.
Australia’s top performing state revealed
Two mining powerhouses are officially Australia’s best performing state economies, with one topping the list for the second time since 2014.
Impossible choice for Aussie families
Australian families are being forced to choose between necessities for their kids’ education or the family home.
Major shake up in Dutton’s front bench
Opposition leader Peter Dutton has announced the long-awaited shake up of his front bench as he looks to the upcoming federal election.